healthcare
-
PBMs and your prescription drug bill
The key to lowering drug costs is increasing competition and not imposing laws or regulations that can have unintended consequences, including higher costs to patients.
-
Be thankful for free markets
As we approach Thanksgiving, during a spiking pandemic, Americans still have much to be grateful for in the arena of their health. One of those things is the U.S. prescription drug market, which is driving innovation that promises to ultimately…
-
Balancing costs with the right drug, at the right time
Understanding what drives cost increases and allowing insurers to make their own decisions regarding pharmacy network and drug coverage will let patients find what works best for them.
-
Prescription Drug Q&A: Reducing the cost of prescription drugs
Cost-saving measures from some prescription drug market players and failures in prescription drug policy often make prescriptions costlier for patients than they need to be. “The biggest shortcomings I see in the current market is the use of the rebate…
-
Despite polarizing presidential election, consensus is growing behind healthcare price transparency
There is a consensus in healthcare policy that is growing increasingly clear: Price transparency for patients’ medical care and prescription drugs will continue to move forward no matter who claims victory in the 2020 elections.
-
Prescription Drug Q&A: The U.S. market and COVID vaccines
“The U.S. has a vibrant and thriving biopharma sector” – says American Enterprise Institute scholar and Milton Friedman chair James C. Capretta – “in large part because the payments system for these products is more favorable to the industry than…
-
Prescription Drug Q&A: The U.S. market-based system makes it a world leader in discovering new medicines
Americans get what they pay for when it comes to prescription drugs. We pay higher prices for drugs but gain access to nearly twice as many new medicines as citizens in foreign countries that use the law or government programs…
-
VP debate illustrates need for serious policy solutions – not slogans
As we go into the closing stretch of the 2020 election season, remember that slogans are not solutions. Remember that there are important tradeoffs to consider in any major healthcare policy proposal.
-
Prescription Drugs 101: Executive order on international reference pricing
The example of international reference pricing is just one of many prescription drug policy reforms that can (and will) have unintended consequences and unpredictable impacts.
-
Sutherland signs open letter on healthcare reform
“Americans know we need real change. You want to be in charge of your health care without asking Washington politicians or health insurance bureaucrats for permission.”